UAB "Grožio Medicina" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 398,497 |
| 398,497 |
| 43,986 |
| 41,999 |
| 41,999 |
| 11.17 |
| 10.54 |
| 1,618,490 |
| 3,519,317 |
| 283,757 |
| 4,852,936 |
| 11.67 |
| 2.17 |
| - |
| - |
| -6.87 |
| -27,382 |
| 2024 |
|---|
| 354,619 |
| 354,619 |
| 189,027 |
| 167,097 |
| 167,097 |
| 64.47 |
| 47.12 |
| 1,785,587 |
| 3,373,517 |
| 521,451 |
| 4,637,653 |
| 12.29 |
| 1.89 |
| - |
| - |
| 48.05 |
| 170,386 |
| 2025 |
|---|
| 97,043 |
| 97,043 |
| 99,256 |
| 82,209 |
| 82,209 |
| 96.60 |
| 84.71 |
| 1,867,796 |
| 2,970,986 |
| 507,092 |
| 4,331,690 |
| 43.67 |
| 1.59 |
| - |
| - |
| 42.99 |
| 41,717 |
| 2025 |
|---|
| 97,043 |
| 97,043 |
| 99,256 |
| 82,209 |
| 82,209 |
| 96.60 |
| 84.71 |
| 1,867,796 |
| 2,970,986 |
| 507,092 |
| 4,331,690 |
| 43.67 |
| 1.59 |
| - |
| - |
| 42.99 |
| 41,717 |
Turnover (€)
2025
Turnover (€)
97,043 €-73 % *
Sales per employee (€)
97,043 €-73 % *
Profit before tax (€)
99,256 €-47 % *
Net Profit (€)
82,209 €-51 % *
Profit per employee (€)
82,209 €-51 % *
Total profitability (%)
96.60 %49.84 % *
Net profitability (%)
84.71 %79.78 % *
Equity (€)
1,867,796 €5 % *
Amounts Payable And Liabilities (€)
2,970,986 €-12 % *
Non-current Assets (€)
507,092 €-3 % *
CurrentAssets (€)
4,331,690 €-7 % *
Working capital requirement
43.67 255.33 % *
Debt-to-equity ratio
1.59 -15.87 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
42.99 %-10.53 % *
EBIT (€)
41,717 €-76 % *
